STERIALS

A biopharmaceutical company focused on identifying, developing and commercializing novel treatments for bacterial infections, including multidrug-resistant infections and rare diseases. The company is developing treatments for rare diseases such as nontuberculous mycobacterial lung disease, gram-negative hospital-acquired infections, and complicated urinary tract infections. The company is based in Delaware.